Literature DB >> 27583875

A comparison of the Plusoptix S09 with an autorefractometer of noncycloplegics and cycloplegics in children.

Jae Yon Won1, Hye Young Shin, Su Young Kim, Young Chun Lee.   

Abstract

The aim of the study is to compare outcome measures of refractive error obtained using the Plusoptix S09 photorefractor and an autorefractometer of noncycloplegics and cycloplegics in children.We reviewed the medical records of 40 patients (77 eyes) who were classified using 2 methods. The patients were first assigned to 2 groups consisting of 11 eyes with ≥+3.0 D and 66 eyes with <+3.0 D, and then to 2 groups of 12 and 65 eyes with cycloplegic and noncycloplegic refraction of spherical powers ≥+2.0 D and <+2.0 D, respectively. We compared the outcome measures of refractive error using the Plusoptix S09 photorefractor and an autorefractometer of noncycloplegics and cycloplegics.There was no statistically significant difference between the Plusoptix S09 photorefractor and cycloplegic autorefractometer in the spherical power and spherical equivalent. In contrast, there was a statistically significant difference between the Plusoptix S09 photorefractor and noncycloplegic autorefractometer (P < 0.001). There was a statistically significant difference between the spherical equivalent of the Plusoptix S09 photorefractor and cycloplegic autorefractometer in children with hyperopia ≥+3.0D and with cycloplegic and noncycloplegic refraction of spherical power ≥+2.0 D. We also found a significant difference between the outcomes of the Plusoptix S09 photorefractor and cycloplegic autorefractometer in the spherical power and spherical equivalent for children with hyperopia ≥+3.0 D.The refractive error of the Plusoptix S09 photorefractor was similar to that of the cycloplegic autorefractometer, in contrast to the noncycloplegic autorefractometer. However, the Plusoptix S09 photorefractor is an inaccurate tool to estimate the refractive errors of children with moderate hyperopia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27583875      PMCID: PMC5008559          DOI: 10.1097/MD.0000000000004596

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Amblyopia is the leading cause of decreased vision among children, with refractive errors as the most important cause of this condition.[ Because of the importance of early diagnosis and treatment of amblyopia, several different screening methods have been assessed for children. Cycloplegic refraction is currently the gold standard method for detecting refractive errors.[ However, this method is limited because it requires an experienced examiner and an excessive amount of time.[ To overcome these limitations, several photorefractors were developed. Among these was the Plusoptix S09 photorefractor (Plusoptix GmbH, Nuernberg, Germany), developed for children and the disabled, and is a noninvasive tool for the rapid assessment of both eyes for refractive errors, pupil size, and inter-pupillary distance.[ We investigated the effectiveness of the Plusoptix S09 photorefractor in children.

Methods

In total 77 eyes in 40 children aged 2 to 10 years were evaluated in Uijeongbu St. Mary's Hospital from October 9, 2012, to November 30, 2012. This study was conducted according to the guidelines of the Association for Research in Vision and Ophthalmology and the 1975 Declaration of Helsinki. Furthermore, parental consent was obtained prior to the start of the procedure. Children were excluded when they had eccentric fixation, optical media opacity, or exceeded the Plusoptix S09 manufacturer's recommendations of a refractive error of a maximum spherical range of –7.00 to +5.00 D and a pupil size range of 3 to 8 mm.[ The patients were categorized according to 2 methods: (i) 11 eyes with hyperopia ≥+3.0 D and 66 eyes with hyperopia <+3.0 D, emmetropia, and myopia; (ii) 12 eyes with cycloplegic and noncycloplegic refraction of spherical power ≥+2.0 D and 65 eyes with cyclopegic and noncycloplegic refraction of spherical power <+2.0 D. All refractive errors (spherical power, cylinder power, and spherical equivalent) were determined in the following order: (1) photorefraction without cycloplegia using the Plusoptix S09; (2) autorefraction without cycloplegia (noncycloplegic) using the Cannon autorefractometer (RK-F1, Canon, Tokyo, Japan); (3) cycloplegic autorefractometer using 1% cyclopentolate (1% Cyclogyl®). All cycloplegic autorefractomery was performed within 30 minutes of the use of 1% cyclopentolate 3 times per 5 minutes. Comparisons between the measurements were performed using paired t-tests and Pearson's correlation analysis. All statistical analyses were performed using the SPSS statistical package 19 (SPSS for Windows, Chicago, IL). A value of P < 0.05 was taken to indicate statistical significance.

Results

There was no statistical difference between the 11 eyes with hyperopia of ≥+3.0 D and the 66 eyes with hyperopia of <+3.0 D, emmetropia and myopia for age and sex. In addition, there was no statistical difference between the 12 eyes with cycloplegic and noncycloplegic refraction of spherical power ≥+2.0 D and the 65 eyes with cyclopegic and noncycloplegic refraction of spherical power <+2.0 D (Table 1). There was no difference between the Plusoptix S09 and cycloplegic autorefractometer for both spherical power and equivalent in all of the children. In contrast, there was a statistical difference between the Plusoptix S09 and noncycloplegic autorefractometer (P < 0.001) (Table 2). Pearson's correlations between the Plusoptix S09 and cycloplegic autorefractometer for spherical power, cylinder power, and spherical equivalent were 0.748, 0.893, and 0.782, respectively, whereas between the Plusoptix S09 and noncycloplegic autorefractometer these were 0.559, 0.870, and 0.580, respectively. These results indicate that the spherical power and spherical equivalent determined using the Plusoptix S09 correlated more closely with those determined using the cycloplegic autorefractometer than using the noncycloplegic autorefractometer (Table 3). Although there was no statistical difference between the Plusoptix S09 and cycloplegic autorefractometer in the spherical power and spherical equivalent in all of the patients (Table 2), the mean spherical power and equivalent recorded using the Plusoptix S09 was 2.91 ± 0.90 D and 2.22 ± 0.93 D, respectively, whereas these recorded using the cycloplegic autorefractometer were 4.66 ± 0.93 D and 4.25 ± 0.80 D in hyperopia of ≥+3.0 D, respectively. There was a statistical difference between the Plusoptix S09 and cycloplegic autorefractometer for the spherical power and spherical equivalent in hyperopia of ≥+3.0 D (paired t-test, P < 0.05). In addition, in patients of cycloplegic and noncycloplegic refraction of spherical power ≥+2.0 D, there was a statistical difference between the Plusoptix S09 and cycloplegic autorefractometer for the spherical equivalent (paired t-test, P = 0.015) (Table 4). There was significant difference between the Plusoptix S09 and cycloplegic autorefractometer according to the scatter plot for spherical power and equivalent in hyperopia of ≥+3.0 D (Fig. 1).
Table 1

Patient demographics.

Table 2

Mean values of refractive parameters.

Table 3

Correlation coefficient values between 3 methods for refractive parameters.

Table 4

Mean values of refractive parameters at subgroups.

Figure 1

Scatterplot comparing refractive parameters via 2 methods. CPR = cycloplegic refraction, SE = spherical equivalent, SP = spherical power.

Patient demographics. Mean values of refractive parameters. Correlation coefficient values between 3 methods for refractive parameters. Mean values of refractive parameters at subgroups. Scatterplot comparing refractive parameters via 2 methods. CPR = cycloplegic refraction, SE = spherical equivalent, SP = spherical power.

Discussion

Amblyopia is the leading cause of decreased vision among children and affects 2% to 5% of the population.[ Early diagnosis and treatment may lead to better visual outcomes and decrease the severity and prevalence of amblyopia.[ Because of the importance of early diagnosis, several screening methods for amblyopia are used. The gold standard for detecting refractive error is cycloplegic refraction.[ However, this method is limited because it requires an experienced examiner, is time consuming, and in general needs sedation of children <3 years old with limited co-operation. In contrast, the photo refractor is easy to use in examining younger children without the need for cycloplegic drops or sedation. Although an ideal screening test would have 100% specificity, 100% sensitivity, and 100% positive predictive value, there is no screening method with this level of accuracy.[ Many studies have shown the Plusoptix to be a rapid, accurate, and noninvasive refractometer in preschool children and in individuals with intellectual or physical disabilities, and it has excellent specificity and sensitivity.[ The mean spherical power and spherical equivalent recorded using the Plusoptix S09 were 1.53 ± 2.01 D and 1.33 ± 1.97 D, respectively, whereas using the cycloplegic autorefractometer they were 0.61 ± 2.02 D and 0.73 ± 2.05 D, respectively, in all the children, which were not significantly different between the 2 devices (paired t-test, P > 0.05). We observed significant Pearson's correlation coefficients of 0.748, 0.893, and 0.782 between the Plusoptix S09 and cycloplegic autorefractometer for spherical, cylindrical, and spherical equivalent refractive errors, respectively. These values are similar to those of 0.76, 0.86, and 0.76, respectively, reported by Rajavi et al.[ In contrast, the mean spherical power and spherical equivalent were significantly different using the Plusoptix S09 (2.91 ± 0.90 D and 2.22 ± 0.93 D, respectively) and the cycloplegic autorefractometer (4.66 ± 0.93 D and 4.25 ± 0.80 D, respectively) in hyperopia of ≥+3.0 D, (paired t-test, P < 0.05). Because accommodative capacity leads to a myopic shift in over-moderate hyperopia, a statistical difference between the Plusoptix S09 and cycloplegic autorefractometer for the spherical power and equivalent was expected. This shift was reported to be 3.0 D and 1.9 D in some children by Erdurmus et al[ and Dahlmann-Noor et al,[ respectively. Schaeffel et al[ demonstrated a myopic shift of 2.4 D in children wearing +3.0 D glasses with noncycloplegic photorefraction. In conclusion, the Plusoptix S09 can provide a rapid and easy method of refraction for amblyopia screening in young children and detecting risk factors for refractive amblyopia. However, when it is used to estimate the refractive error in a child with hyperopia of ≥+3.0 D, the refractive error should be corrected after a comparison of the refractive errors of the Plusoptix S09 with those of a cycloplegic autorefractometer.
  10 in total

Review 1.  Vision screening in preschool children: do the data support universal screening?

Authors:  Wolf A Lagrèze
Journal:  Dtsch Arztebl Int       Date:  2010-07-12       Impact factor: 5.594

2.  A comparison of photorefraction and retinoscopy in children.

Authors:  Mesut Erdurmus; Ramazan Yagci; Remzi Karadag; Mustafa Durmus
Journal:  J AAPOS       Date:  2007-06-25       Impact factor: 1.220

3.  Plusoptix Vision Screener: the accuracy and repeatability of refractive measurements using a new autorefractor.

Authors:  A H Dahlmann-Noor; O Comyn; V Kostakis; A Misra; N Gupta; J Heath; J Brown; A Iron; S McGill; K Vrotsou; A J Vivian
Journal:  Br J Ophthalmol       Date:  2008-11-10       Impact factor: 4.638

Review 4.  Effectiveness of early in comparison to late(r) treatment in children with amblyopia or its risk factors: a systematic review.

Authors:  Christine Schmucker; Jos Kleijnen; Robert Grosselfinger; Rob Riemsma; Gerd Antes; Stefan Lange; Wolf Lagrèze
Journal:  Ophthalmic Epidemiol       Date:  2010 Jan-Feb       Impact factor: 1.648

5.  Validation of plusoptiX S04 photoscreener as a vision screening tool in children with intellectual disability.

Authors:  Silay Canturk Ugurbas; Atilla Alpay; Huseyin Tutar; Haci Murat Sagdik; Suat Hayri Ugurbas
Journal:  J AAPOS       Date:  2011-10       Impact factor: 1.220

Review 6.  Preschool vision screening: rationale, methodology and outcome.

Authors:  K Simons
Journal:  Surv Ophthalmol       Date:  1996 Jul-Aug       Impact factor: 6.048

7.  Performance of the Plusoptix vision screener for the detection of amblyopia risk factors in children.

Authors:  Noelle S Matta; Eric L Singman; David I Silbert
Journal:  J AAPOS       Date:  2008-06-05       Impact factor: 1.220

8.  Efficiency of a video-autorefractometer used as a screening device for amblyogenic factors.

Authors:  Thilo Schimitzek; Wolfgang Haase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-08-27       Impact factor: 3.117

9.  Noncycloplegic photorefractive screening in pre-school children with the "PowerRefractor" in a pediatric practice.

Authors:  Frank Schaeffel; Ute Mathis; Gunther Brüggemann
Journal:  Optom Vis Sci       Date:  2007-07       Impact factor: 1.973

10.  Is noncycloplegic photorefraction applicable for screening refractive amblyopia risk factors?

Authors:  Zhale Rajavi; Hiva Parsafar; Alireza Ramezani; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2012-01
  10 in total
  4 in total

1.  Difference of refraction values between standard autorefractometry and Plusoptix.

Authors:  Camelia Margareta Bogdănici; Codrina Maria Săndulache; Rodica Vasiliu; Otilia Obadă
Journal:  Rom J Ophthalmol       Date:  2016 Oct-Dec

2.  Comparison of Autorefraction and Photorefraction with and without Cycloplegia Using 1% Tropicamide in Preschool Children.

Authors:  Ertuğrul Tan Yassa; Cihan Ünlü
Journal:  J Ophthalmol       Date:  2019-05-02       Impact factor: 1.909

3.  Comparison between Plusoptix A09 and gold standard cycloplegic refraction in preschool children and agreement to detect refractive amblyogenic risk factors.

Authors:  Jyothi Thomas; B Rajashekar; Asha Kamath; Parikshit Gogate
Journal:  Oman J Ophthalmol       Date:  2021-02-27

4.  Comparative Validation of PlusoptiX and AI-Optic Photoscreeners in Children with High Amblyopia Risk Factor Prevalence.

Authors:  Robert W Arnold
Journal:  Clin Ophthalmol       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.